Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever received at the company. | While Stéphane Bancel received a ...

Covid was a privatized pandemic. It is this technocratic, privatized model that is its lasting legacy and that will define ...

Introduction Vaccines are biological preparations that stimulate the immune system to develop protection against specific infectious diseases.

Moderna is advancing its oncology portfolio with individualized neoantigen therapy (INT) and T-cell engagers. The company anticipates data readouts for melanoma and CMV vaccine trials in 2026 and ...

Solano County issued a countywide Shelter at Home Health Order and Directive to continue protecting the health and safety of ...

Now the nation’s top health official, Kennedy is reevaluating the US Health and Human Services’s contract with Moderna, which ...

Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...

Mutual of America Capital Management LLC trimmed its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 2.6% during the ...

CompanyOverview|NASDAQ:MRNA] The CEO of Moderna Inc. (NASDAQ: MRNA) just purchased $5 million of stock in the open market.

The National Institutes of Health, which falls under the jurisdiction of HHS, has terminated grants for research into vaccine hesitancy, according to the Washington Post, even though the Texas measles ...